François-Xavier Lamy

561 total citations
35 papers, 376 citations indexed

About

François-Xavier Lamy is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, François-Xavier Lamy has authored 35 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Economics and Econometrics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in François-Xavier Lamy's work include Economic and Financial Impacts of Cancer (10 papers), Colorectal Cancer Treatments and Studies (7 papers) and Treatment of Major Depression (7 papers). François-Xavier Lamy is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Colorectal Cancer Treatments and Studies (7 papers) and Treatment of Major Depression (7 papers). François-Xavier Lamy collaborates with scholars based in Germany, France and United States. François-Xavier Lamy's co-authors include Delphine Saragoussi, Jacques Dantal, Yvon Lebranchu, Sophie Caillard, P Lang, Bruno Moulin, Michel Velten, Raymond W. Lam, Natalya Danchenko and Michelle K. White and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

François-Xavier Lamy

33 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François-Xavier Lamy Germany 8 170 82 62 62 54 35 376
Adeel Nasir United States 4 31 0.2× 55 0.7× 32 0.5× 70 1.1× 57 1.1× 6 428
Brent Diekmann United States 9 149 0.9× 7 0.1× 67 1.1× 12 0.2× 28 0.5× 9 532
Carolyn Harris United States 11 129 0.8× 9 0.1× 30 0.5× 41 0.7× 19 0.4× 42 355
Swapna Karkare United States 11 49 0.3× 38 0.5× 166 2.7× 11 0.2× 42 0.8× 25 447
Amanda Grattan Australia 5 106 0.6× 81 1.0× 14 0.2× 8 0.1× 49 0.9× 7 355
K Holden United Kingdom 14 22 0.1× 17 0.2× 19 0.3× 11 0.2× 64 1.2× 20 417
Carol Beth Stewart United States 11 308 1.8× 11 0.1× 19 0.3× 25 0.4× 55 1.0× 19 509
Blaire Anderson Canada 12 147 0.9× 25 0.3× 25 0.4× 4 0.1× 424 7.9× 32 670
Pleun J. de Raaf Netherlands 8 362 2.1× 23 0.3× 9 0.1× 14 0.2× 34 0.6× 10 575

Countries citing papers authored by François-Xavier Lamy

Since Specialization
Citations

This map shows the geographic impact of François-Xavier Lamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François-Xavier Lamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François-Xavier Lamy more than expected).

Fields of papers citing papers by François-Xavier Lamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François-Xavier Lamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François-Xavier Lamy. The network helps show where François-Xavier Lamy may publish in the future.

Co-authorship network of co-authors of François-Xavier Lamy

This figure shows the co-authorship network connecting the top 25 collaborators of François-Xavier Lamy. A scholar is included among the top collaborators of François-Xavier Lamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François-Xavier Lamy. François-Xavier Lamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sørup, Signe, Bianka Darvalics, Leo Russo, et al.. (2021). High‐dose corticosteroid use and risk of hospitalization for infection in patients treated with immune checkpoint inhibitors––A nationwide register‐based cohort study. Cancer Medicine. 10(14). 4957–4963. 6 indexed citations
2.
Zhang, Xinke, Daniel C. Beachler, Elizabeth T. Masters, et al.. (2021). Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States. Journal of Managed Care & Specialty Pharmacy. 28(2). 255–265. 17 indexed citations
3.
Boutmy, Emmanuelle, et al.. (2021). Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer. Journal of Comparative Effectiveness Research. 10(5). 353–364. 5 indexed citations
4.
Beachler, Daniel C., François-Xavier Lamy, Leo Russo, et al.. (2020). A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer. Journal of Ovarian Research. 13(1). 101–101. 12 indexed citations
5.
Kasper, Stefan, Diethelm Messinger, Regina Esser, et al.. (2020). Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer. European Journal of Cancer. 144. 291–301. 7 indexed citations
6.
Batech, Michael, et al.. (2020). Overall survival of cetuximab administered every two weeks versus weekly in real-world data of U.S. patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 38(4_suppl). 23–23. 2 indexed citations
7.
8.
Falissard, Bruno, Fabien Picard, Isabelle Mahé, et al.. (2019). Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice. Archives of cardiovascular diseases. 112(6-7). 400–409. 6 indexed citations
9.
Esposito, Daina B., Leo Russo, Ruihua Yin, et al.. (2019). Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database. Cancer Epidemiology. 61. 30–37. 11 indexed citations
10.
Haro, Josep María, François-Xavier Lamy, Bengt Jönsson, et al.. (2018). Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study. BMC Psychiatry. 18(1). 80–80. 6 indexed citations
11.
Lamy, François-Xavier, et al.. (2017). The use of adjunctive antipsychotics to treat depression in UK primary care. Current Medical Research and Opinion. 33(5). 891–898. 7 indexed citations
12.
Lamy, François-Xavier, et al.. (2015). Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis. Current Medical Research and Opinion. 31(4). 795–807. 4 indexed citations
13.
Lamy, François-Xavier, et al.. (2014). Economic Burden of Major Depressive Disorder (Mdd) in Five European Countries: Description of Resource use by Health State. Value in Health. 17(7). A465–A465. 5 indexed citations
14.
Lamy, François-Xavier, C. Cantrelle, M. Stern, et al.. (2013). Eligibility and Availability of Lungs for Transplantation: The French Experience. The Journal of Heart and Lung Transplantation. 32(4). S154–S154. 3 indexed citations
15.
Lam, Raymond W., et al.. (2013). Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD). Value in Health. 16(7). A330–A330. 37 indexed citations
16.
Boulenger, J.P., et al.. (2013). The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study. Value in Health. 16(7). A543–A543. 1 indexed citations
17.
Caillard, Sophie, François-Xavier Lamy, Jacques Dantal, et al.. (2012). Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas. American Journal of Transplantation. 12(3). 682–693. 136 indexed citations
18.
Lamy, François-Xavier, et al.. (2012). Prélèvement d’organes en France : état des lieux et perspectives. La Presse Médicale. 42(3). 295–308. 6 indexed citations
19.
Lamy, François-Xavier, Émilie Savoye, Marie‐Alice Macher, & Marie Thuong. (2011). Bilan et perspectives de l’activité de greffe rénale à partir de donneur vivant en France. Néphrologie & Thérapeutique. 7(7). 535–543. 5 indexed citations
20.
Dorent, Richard, François-Xavier Lamy, & C. Cantrelle. (2010). Le rôle de l’Agence de la biomédecine dans la greffe pulmonaire. Revue de Pneumologie Clinique. 67(1). 57–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adeel Nasir Breakdown of academic impact, for papers by Brent Diekmann Breakdown of academic impact, for papers by Carolyn Harris Breakdown of academic impact, for papers by Swapna Karkare Breakdown of academic impact, for papers by Amanda Grattan Breakdown of academic impact, for papers by K Holden Breakdown of academic impact, for papers by Carol Beth Stewart Breakdown of academic impact, for papers by Blaire Anderson Breakdown of academic impact, for papers by Pleun J. de Raaf
Rankless by CCL
2026